Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $757.76 | 38 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $131.22 | 5 | $0 (2020) |
| Amgen Inc. | $95.06 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $86.75 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $61.31 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $57.25 | 3 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $52.10 | 2 | $0 (2020) |
| One Lambda, Inc. | $48.63 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $40.39 | 2 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $39.49 | 2 | $0 (2022) |
| Mallinckrodt LLC | $28.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $127.06 | 7 | Boehringer Ingelheim Pharmaceuticals, Inc. ($40.39) |
| 2021 | $160.82 | 8 | One Lambda, Inc. ($48.63) |
| 2020 | $111.18 | 6 | Amgen Inc. ($33.65) |
| 2019 | $57.08 | 3 | Actelion Pharmaceuticals US, Inc. ($22.97) |
| 2018 | $137.80 | 6 | Abbott Laboratories ($81.45) |
| 2017 | $163.82 | 8 | Astellas Pharma US Inc ($37.84) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/08/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardiology | ||||||
| 02/28/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: DIABETES | ||||||
| 02/25/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: DIABETES | ||||||
| 01/27/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/22/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: Cardiology | ||||||
| 09/04/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/09/2021 | One Lambda, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.63 | General |
| 06/25/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/22/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/14/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/06/2020 | Medtronic Vascular, Inc. | 3F (Device) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Heart Valves | ||||||
| 06/23/2020 | Medtronic Vascular, Inc. | 3F (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Heart Valves | ||||||
| 06/17/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: Cardiology | ||||||
| 03/09/2020 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/27/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: Cardiology | ||||||
| 01/06/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology | ||||||
| 12/11/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2019 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Cardiology | ||||||
| 01/14/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: KRYSTEXXA | ||||||
| 11/21/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 54 | 74 | $12,950 | $4,402 |
| 2021 | 5 | 193 | 629 | $125,176 | $46,922 |
| 2020 | 6 | 200 | 708 | $142,046 | $48,591 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 54 | 74 | $12,950 | $4,402 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 92 | 251 | $43,925 | $18,459 | 42.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 149 | $36,356 | $12,255 | 33.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 179 | $29,535 | $10,127 | 34.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 20 | 22 | $8,360 | $3,310 | 39.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 28 | 28 | $7,000 | $2,771 | 39.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 202 | $49,288 | $16,785 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 101 | 248 | $43,400 | $13,716 | 31.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 197 | $32,505 | $11,403 | 35.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 21 | 25 | $9,458 | $4,099 | 43.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 21 | 21 | $5,250 | $1,699 | 32.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 11 | 15 | $2,145 | $888.80 | 41.4% |
About Dr. Judson Hunt, M.D
Dr. Judson Hunt, M.D is a Nephrology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316925803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judson Hunt, M.D has received a total of $757.76 in payments from pharmaceutical and medical device companies, with $127.06 received in 2022. These payments were reported across 38 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($757.76).
As a Medicare-enrolled provider, Hunt has provided services to 447 Medicare beneficiaries, totaling 1,411 services with total Medicare billing of $99,915. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Dallas, TX
- Active Since 01/04/2006
- Last Updated 08/27/2009
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1316925803
Products in Payments
- ENTRESTO (Drug) $86.75
- BRILINTA (Drug) $61.31
- Corlanor (Drug) $54.27
- UPTRAVI (Drug) $52.10
- HeartMate (Device) $45.68
- Repatha (Biological) $40.79
- JARDIANCE (Drug) $40.39
- HeartMate 3 Left Ventricular Dev (Device) $39.85
- LifeVest (Device) $39.49
- ACTHAR (Biological) $28.65
- CardioMEMS HF System (Device) $28.57
- 3F (Device) $27.20
- Envarsus XR (SP) (Drug) $21.88
- PROGRAF (Drug) $19.41
- Prograf (Drug) $19.39
- BYSTOLIC (Drug) $18.66
- Astagraf (Drug) $18.45
- INVOKANA (Drug) $17.47
- Circulatory Support (Device) $17.12
- KRYSTEXXA (Biological) $16.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Dallas
Dr. Ankit Mehta, M.d, M.D
Nephrology — Payments: $907,733
Irfan Agha, M.d, M.D
Nephrology — Payments: $278,709
Robert Toto, Md, MD
Nephrology — Payments: $199,974
Russell Silverstein, M.d, M.D
Nephrology — Payments: $190,316
Christopher Hebert, Md, MD
Nephrology — Payments: $174,262
Dr. Sumit Kumar, M.d, M.D
Nephrology — Payments: $158,458